Project: Combination of a hybrid scaffold material with cold adapted marine enzymes for wound healing
The partners intend to develop a hybrid scaffold material with microencapsulated marine derived proteins for advanced wound care. This combination will enable increased wound healing through improved exudate and infection management and improved occlusiveness leading to evaporation control. This combination will also improve the life quality of patients. The final product will be registered as a class IIa medical device and promoted as a high value product which holds medical claims
Acronym | Hybrizyme (Reference Number: 9695) |
Duration | 01/09/2015 - 01/09/2018 |
Project Topic | Biological Sciences / Technologies |
Network | Eurostars 2 |
Call | Eurostars Cut-Off 3 |